Traitement de l'aphtose récurrente par thalidomide à faible dose. Étude pilote chez 17 patients
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 20 (7) , 567-570
- https://doi.org/10.1016/s0248-8663(99)80105-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet SyndromeAnnals of Internal Medicine, 1998
- Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-α) inhibition suggest drugs capable of selective gene regulationClinical and Experimental Immunology, 1997
- New roles for thalidomideBMJ, 1996
- Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.Annals of the Rheumatic Diseases, 1994
- II. The Effects of Thalidomide Treatment on Autoimmune‐Prone NZB and MRL Mice are Consistent with Stimulation of the Central Immune SystemScandinavian Journal of Immunology, 1994
- Thalidomide NeuropathyNew England Journal of Medicine, 1992
- Thalidomide for the Treatment of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1992
- Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitisArchives of Dermatology, 1990
- Treatment of aphthae with thalidomideJournal of the American Academy of Dermatology, 1989
- Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.Journal of Neurology, Neurosurgery & Psychiatry, 1968